Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/10/20
End: 03/31/24
Due: 03/31/25
Phase: N/A
Priority: Normal
Start: 06/01/20
End: 05/31/30
Due: 05/31/31
Phase: N/A
Priority: Normal
Start: 05/09/20
End: 12/31/26
Due: 12/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone | NCT04158947 | xuexin he | user2@example.com | None | 2020-05-10 | 2024-03-31 | 2025-03-31 | - | - | 2025-07-14 |
| Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer | NCT04158856 | xuexin he | user2@example.com | None | 2020-06-01 | 2030-05-31 | 2031-05-31 | - | - | 2025-07-14 |
| Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis | NCT04158843 | xuexin he | user2@example.com | None | 2020-05-09 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |